Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Soizick Mesnage"'
Autor:
Michael T. Richardson, Catherine Genestie, Sebastien Gouy, Amandine Maulard, Soizick Mesnage, Philippe Morice, Elisa Yaniz Galende, Patricia Pautier, Alexandra Leary, Audrey Le Formal, Chloé Brizais, F. Blanc-Durand
Publikováno v:
Gynecologic Oncology. 160:279-284
Background The disappointing activity of single agent immune-checkpoint inhibitors in epitherlial ovarian cancer (EOC) has been attributed in part to its unique tumor microenvironment (TME). IDO, PDL1, LAG3 and TIM3 have been implicated in the immuno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b7f80ae71688bb51d52d829f8b27bbf
https://doi.org/10.1016/j.ygyno.2020.09.045
https://doi.org/10.1016/j.ygyno.2020.09.045
Autor:
Françoise Drusch, Judith Michels, Philippe Morice, Aya S. Khairallah, Amandine Maulard, Sebastien Gouy, Enrica Bentivegna, Bianca Cheaib, Audrey LeFormal, Catherine Genestie, Soizick Mesnage, Patricia Pautier, Ariane Dunant, Alexandra Leary, F. Blanc-Durand
Publikováno v:
Cancer Immunology, Immunotherapy
Background At diagnosis, tumor-infiltrating lymphocytes (TILs) are prognostic in epithelial ovarian cancer (EOC). We recently demonstrated that neoadjuvant chemotherapy (NACT) significantly increased stromal TILs. Here, we investigated the impact of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96b40b6b94b912035324454c3b3e0a7e
https://doi.org/10.1007/s00262-020-02670-0
https://doi.org/10.1007/s00262-020-02670-0
Autor:
Colin R Lindsay, Pier Francesco Ferrucci, Giuseppe Tonini, Dara Stein, Victoria Atkinson, Paola Queirolo, Barbara Merelli, Philippe Legenne, Massimo Aglietta, Klaus Freivogel, Soizick Mesnage, Michele Del Vecchio, Helen Linardou, Bart Neyns, Salvador Martín-Algarra, Lindi Dalland, Vanna Chiarion-Sileni, Michael Millward, Jonathan Cebon, Rebecca A. Hinshelwood, Mike Lau
Publikováno v:
Melanoma Research. 29:527-532
Given the approval of dabrafenib in patients with BRAF-mutant metastatic melanoma, a better understanding of treatment patterns and clinical outcomes with dabrafenib in a clinical setting is warranted. We performed a retrospective chart review of pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::753c385f5f7c5162c1195b0a46912e27
https://doi.org/10.1097/cmr.0000000000000608
https://doi.org/10.1097/cmr.0000000000000608
Autor:
Michael Findlay, Soizick Mesnage, Kathryn Payne, Cherie Blenkiron, Cris Print, Rosalie Stephens, PS Houseman, Paula Shields, Tamsin Robb, Kathryn F. Chrystal, H Hameed, Michelle Wilson
Publikováno v:
Poster.
Introduction In clear cell ovarian cancers (CCOC) limited data is available on genomic evolution with disease progression. Methods 23 FFPE tumours collected from 12 patients with advanced CCOC, and 1 mixed clear cell endometrioid OC, treated at Auckl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a9f6d1c263b6c04e3194c7a86897dc8
https://doi.org/10.1136/ijgc-2020-igcs.316
https://doi.org/10.1136/ijgc-2020-igcs.316
Publikováno v:
Current Opinion in Oncology. 28:404-411
Purpose of review The proven activity of poly ADP ribose polymerase (PARP) inhibitors in BRCA-mutated homologous recombination deficient (HRD) ovarian cancer has led to the availability to patients with ovarian cancer of the first targeted therapy wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec035082c66140d91f74f8fd73fe9839
https://doi.org/10.1097/cco.0000000000000320
https://doi.org/10.1097/cco.0000000000000320
Autor:
P. Morice, Françoise Drusch, A. Le Formal, E. Bentivegna, Alexandra Leary, Aurélie Auguste, Patricia Pautier, Soizick Mesnage, Catherine Genestie, Erwann Pain, Judith Michels, Bianca Cheaib, Julien Adam, Sebastien Gouy, Catherine Lhommé, Ariane Dunant
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 28(3)
Lymphocytic infiltration at diagnosis is prognostic in EOC, however, the impact of NACT on tumour infiltrating lymphocytes (TILs) or PD-L1 expression remains poorly described.Patients with EOC and sequential samples (pre-NACT, post-NACT or relapse) w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9e971d13ff44f2c0115dbc196674863
https://pubmed.ncbi.nlm.nih.gov/27864219
https://pubmed.ncbi.nlm.nih.gov/27864219
Autor:
Sebastien Gouy, P. Morice, E. Bentivegna, Marc Deloger, Catherine Genestie, Patricia Pautier, Soizick Mesnage, Bastien Job, Yannick Boursin, Alexandra Leary, Julien Adam, Judith Michels, A. Leformal-Ensarguex, Aurélie Auguste
Publikováno v:
Annals of Oncology. 28:v337-v338
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a7dfe40b436d98127c6878228d4c3bf
https://doi.org/10.1093/annonc/mdx372.019
https://doi.org/10.1093/annonc/mdx372.019
Autor:
Peter C.C. Fong, Soizick Mesnage, Wilfred Levin, Helen Mackay, Lisa Wang, Kathryn Payne, Kathryn F. Chrystal, Amit M. Oza, Stephane Laframboise, Michelle K. Wilson, Marjan Rouzbahman, Andrew N. Shelling
Publikováno v:
Gynecologic oncology. 138(2)
Optimal management of women with early stage granulosa cell tumours (GCT) presents a management conundrum — they have excellent prognosis but a third will relapse. Advances uncovering the molecular characteristics of GCT have not been matched by im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdf7df5c312983c13c013e95c94622b8
https://pubmed.ncbi.nlm.nih.gov/26003143
https://pubmed.ncbi.nlm.nih.gov/26003143
Autor:
Soizick Mesnage, Enrica Bentivegna, Elena Cojocaru, Sebastien Gouy, Aurélie Auguste, Catherine Genestie, Audrey Le Formal, Alexandra Leary, Julien Adam, Catherine Lhommé, Patricia Pautier, Françoise Drusch
Publikováno v:
Molecular Cancer Research. 15:B02-B02
Background: HGOC is frequently diagnosed at an advanced stage where NeoAdjuvant Chemotherapy (NACT) provides an essential component of the treatment strategy. HGOC are initially very chemosensitive, putatively due to DNA repair defects. While BRCA mu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fd5641c364989f76eb6ca6caa7056ab4
https://doi.org/10.1158/1557-3125.dnarepair16-b02
https://doi.org/10.1158/1557-3125.dnarepair16-b02
Autor:
Catherine Lhommé, Catherine Genestie, Erwann Pain, Philippe Morice, Patricia Pautier, Aurélie Auguste, Bianca Cheaib, Judith Michels, Ariane Dunant, Françoise Drusch, Soizick Mesnage, Enrica Bentivegna, Sebastien Gouy, Audrey Le Formal, Alexandra Leary, Julien Adam
Publikováno v:
Journal of Clinical Oncology. 35:64-64
64 Background: Tumour immune response plays a critical role in progression and prognosis of EOC, however patterns of TILs and PD-L1 expression in primary and metastatic disease remain poorly described. Methods: Patients treated with neoadjuvant chemo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::df007bea3ff07338f7b3278d605b9456
https://doi.org/10.1200/jco.2017.35.7_suppl.64
https://doi.org/10.1200/jco.2017.35.7_suppl.64